Hi Gujarat
Menu
  • Home
  • Business
  • Lifestyle
  • Health
  • Education
  • National
  • PR
Menu

Optimus Announces Interim Clinical Results from Phase III Clinical Trials of Molnupiravir Conducted in India

Posted on July 21, 2021 by Hi Gujarat Webdesk

Hyderabad (Telangana) [India], July 21: Optimus Pharma on Sunday submitted the interim result of Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild Covid-19 patients. With an acute shortage of antiviral drugs in the market against the SARS-CoV-2 infection, it is imperative that more drugs with potent antiviral activity against SARS-CoV-2 be introduced.

In a statement, the MD and Chairman Dr. D Srinivasa Reddy had declared that Optimus pharma has internally developed the active pharmaceutical ingredient (API) and the formulations for the product and had obtained approval for conducting Phase 3 Clinical Trial.

As per the clinical trial protocol approved, 1218 subjects with mild COVID-19 will be randomised in the study in a 1:1 ratio to Molnupiravir with the standard of care, or standard of care alone. The treatment duration is a maximum of 05 days and the total study duration will be a maximum of 28 days from randomisation.

“Optimus is all geared to immediately begin manufacturing of Molnupiravir for COVID-19 patients in India. The interim results on 353 patients have shown promising results of Molnupiravir. The drug has been successful in reducing viral load effectively with RT-PCR negativity achieved 78.3 % in the test arm compared to 48.4% in the standard of care arm on Day 5. Day 10 and Day 14 of the treatment duration have also given excellent results wherein the remaining patients have successfully achieved RT-PCR negativity. The trial has also revealed clinical improvement in a significantly high proportion of patient’s health. The safety of the drug has also been established with no observed side effects, co-morbidity, or morbidity observed during and after the treatment duration,” Chairman & Managing Director – Dr. D Srinivasa Reddy said.

Optimus has approached the Drugs Controller General of India (DCGI) to seek Emergency Use Authorization for Molnupiravir in India.

Optimus Pharma is committed to serve the nation and fight back the pandemic to restore normalcy in the lives of people affected by COVID-19 at the earliest. With the cooperation of the government and our stakeholders, and a special thanks to the Subject Expert Committee of the CDSCO for their valuable contribution and their recommendations to the project, we hope to deliver the product in India by leveraging our solid distribution strength across the country.

1 thought on “Optimus Announces Interim Clinical Results from Phase III Clinical Trials of Molnupiravir Conducted in India”

  1. pausslot says:
    May 4, 2023 at 5:42 am

    Your article has given me a lot to think about and has sparked some great discussions with my friends and family. Thank you for providing such thought-provoking content.

Leave a Reply Cancel reply

Your email address will not be published.

Recent Posts

  • Innovating Monetization Strategies: How Magazine Publishers Thrive in the Digital Era
  • Lincoln Pharmaceuticals Ltd achieves the milestone of Rs. 533 crore Revenue and Rs. 100 crore Profit before Tax for the first time in a Financial Year for FY2022-23
  • BigBloc Construction Ltd Reports Net Profit of Rs. 30.14 crore in FY23, rise of 87.4% Y-o-Y
  • Avani Institute of Design Announces Bachelor of Architecture Undergraduate Program 2023-24
  • IMS Ghaziabad (University Courses Campus) indicates how generative AI technologies have the potential to transform methods of teaching

Recent Comments

  • Ybrekt on Come explore global business opportunities at the Grand 3D Event ‘Global Buyer Seller Meet’ organised by Being Exporter
  • Williamham on Brighter Kashmir’s Objectivity
  • Cbathh on India’s First Most Trustable Multiple Bank Loan Offer Membership Card Provider Company – Nowofloan.Com
  • ThomasNeild on SMEBIZZ Celebrated WORLD MSME DAY
  • Arskhg on Goa Gets A Hot & Grand New Party Destination – Phantom Open Now In Baga

Archives

  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020

Categories

  • A
  • Business
  • Design
  • Education
  • English
  • Entertainment
  • Health
  • Hindi
  • Lifestyle
  • National
  • Press Release
  • Sports
  • Technology
  • Uncategorized
  • World
  • एजुकेशन
  • गुजरात
  • नेशनल
  • बिज़नस
  • लाइफस्टाइल
  • हेल्थ

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
©2023 Hi Gujarat | WordPress Theme by Superbthemes.com